• Small Molecules
    • Services
      • Drug Substance (API)
      • Particle Engineering
      • Drug Product
    • Technologies
      • Highly Potent API (HPAPI)
      • ADCs
      • Spray Dried Dispersions
      • Micronization & Jet Milling
      • Inhaled Delivery (DPI)
    • Solutions
      • Early Phase API
      • Commercial Production API
      • Bioavailability Enhancement
      • Integrated Offerings
    • Knowledge Center
      • Webinars
      • Presentations
      • Publications
      • Meet the Experts
      • View all
    View all Small Molecules offerings
    View all locations
    Clinical drug development & preformulation

    Knowledge Center

    View all the latest resources


    Visit our Knowledge Center

  • Biologics
    • Modalities
      • Mammalian
      • Microbial
      • ADCs / Bioconjugates
      • mRNA / LNP
      • Drug Product
    • Technologies & Products
      • Expression Technologies
      • Discovery Products
      • Bioprocessing Products
    • Discovery and Preclinical
      • Early De-risking & Optimization
      • Cell Line & Strain Development
      • Process Development & Optimization
      • Analytical Development
      • Formulation Development
      • Non-GMP Manufacture
    • Clinical and Commercial
      • Process Development & Optimization
      • Formulation Optimization
      • cGMP Drug Substance Manufacture
      • cGMP Drug Product Manufacture
    Technical Support
    Regulatory Support
    View all locations
    View all Biologics offerings
    Woman and microscope

    Knowledge Center

    View all the latest resources available on site


    Visit our Knowledge Center

  • Cell & Gene
    • Services
      • Process Development
      • cGMP Manufacturing
      • Regulatory Consulting
      • Bioassay Services
      • Tissue Acquisition
    • By Modality
      • Autologous
      • Allogeneic
      • Viral Vectors
      • iPSCs
      • Exosomes
    • Technologies
      • MODA® Platform
      • Cocoon® Platform
      • Nucleofector® Technology
      • TheraPEAK® Media
      • Endotoxin and Pyrogen Testing
    • Knowledge Center
      • Webinars
      • Articles
      • Whitepapers & Publications
      • eBooks
      • Presentations
      • View all
    View all Cell & Gene offerings
    View all Bioscience Products
    View all locations
  • Capsules & Health Ingredients
    • Health Ingredients
    • Nutraceutical capsules
    • Pharmaceutical capsules
    • Capsule filling equipment
  • Contact
Small Molecules
Small Molecules
Services
  • Drug Substance (API)
  • Particle Engineering
  • Drug Product
Technologies
  • Highly Potent API (HPAPI)
  • ADCs
  • Spray Dried Dispersions
  • Micronization & Jet Milling
  • Inhaled Delivery (DPI)
Solutions
  • Early Phase API
  • Commercial Production API
  • Bioavailability Enhancement
  • Integrated Offerings
Knowledge Center
  • Webinars
  • Presentations
  • Publications
  • Meet the Experts
  • View all
Back
Biologics
Biologics
Modalities
  • Mammalian
  • Microbial
  • ADCs / Bioconjugates
  • mRNA / LNP
  • Drug Product
Technologies & Products
  • Expression Technologies
  • Discovery Products
  • Bioprocessing Products
Discovery and Preclinical
  • Early De-risking & Optimization
  • Cell Line & Strain Development
  • Process Development & Optimization
  • Analytical Development
  • Formulation Development
  • Non-GMP Manufacture
Clinical and Commercial
  • Process Development & Optimization
  • Formulation Optimization
  • cGMP Drug Substance Manufacture
  • cGMP Drug Product Manufacture
Back
Cell & Gene
Cell & Gene
Services
  • Process Development
  • cGMP Manufacturing
  • Regulatory Consulting
  • Bioassay Services
  • Tissue Acquisition
By Modality
  • Autologous
  • Allogeneic
  • Viral Vectors
  • iPSCs
  • Exosomes
Technologies
  • MODA® Platform
  • Cocoon® Platform
  • Nucleofector® Technology
  • TheraPEAK® Media
  • Endotoxin and Pyrogen Testing
Knowledge Center
  • Webinars
  • Articles
  • Whitepapers & Publications
  • eBooks
  • Presentations
  • View all
Back
Capsules & Health Ingredients
Capsules & Health Ingredients
Health Ingredients
Nutraceutical capsules
Pharmaceutical capsules
Capsule filling equipment
Back
Contact
Back
  • Home
  • Biologics
  • Mammalian Biopharmaceutical Services
  • Mammalian Drug Substance Manufacturing

Drug Substance Manufacturing

We provide a complete yet flexible development and manufacturing package for your product, to help it reach its full potential. We offer a range of services covering different molecule types, from monoclonal antibodies to more complex next-generation biologics.
Contact our experts
35+ Years' Experience in Mammalian Manufacturing
1 kL - 20 kL Bioreactors for Preclinical to Commercial Manufacturing
7 Production Sites in our Global Network

We offer flexible solutions for the entire lifecycle of your product, from preclinical to commercial stages.

Depending on the needs of your molecule and your program, we can utilize our global network and capabilities to offer the appropriate suite of services. The variety of our offerings provides the flexibility of a complete program, from gene to drug product, or the option to drop in at a later stage depending where you are in your journey.

Explore Ibex® Solutions, our latest game-changing offering

lab techs 

Preclinical to early clinical manufacture

Our preclinical to clinical drug substance manufacturing services offer scales of 1kL-20kL and non-GMP pilot scales from 50L to 500L. Our production sites are state-of-the-art and offer a global solution for your early clinical mammalian manufacturing needs.

Late clinical to commercial manufacture

Our mammalian late clinical to commercial manufacturing services offer scales of 1000L to 20000L. Our bioreactors include both single use technologies up to 2000L scale and stainless-steel reactors from 6000L to 20000L, providing you with the agility to react to changing product demand and readiness for the right commercial scale.

In determining which scale and location is most appropriate for your project, we discuss with you the clinical path, product needs and product launch and commercialization strategy. We consider both your mid and long-term needs.

We have a global network of seven production sites that offer comprehensive clinical and commercial mammalian manufacturing to meet your needs.

Our BLA approach is tailored to your needs

Benefit from access to our extensive experience with writing and supporting the preparation of your BLA/MAA in support of commercialization. We start several new BLA programs per year with an approach that balances different priorities, timelines and risks and provides an overview of the entire program.

We can help you accelerate your product market readiness and reduce overall project time with our mammalian drug substance manufacturing services.

Related Offerings

Fabs, Fusion, Scaffold and Other Recombinant Proteins DNA-to-IND Program
We will screen more clones to find the highest titer clone. The offering is suitable for customers...
Learn More
Ibex® Design | Standard mAbs DNA-to-IND Program
Benefit from our fixed price, fastest DNA-to-IND program that minimizes risk and uncertainty from...
Learn More
Bispecific Antibodies DNA-to-IND Program
We provide an integrated drug substance/drug product DNA to IND program with reliable timelines...
Learn More
Mammalian Cell Line Development
Benefit from our flexible approach to cell line development matching your project’s priorities in...
Learn More
Mammalian Process Development
We provide access mammalian cell culture process development, optimization and validation services...
Learn More
Mammalian Analytical Development
We provide analytical capabilities encompassing a wide range of technologies to support all stages...
Learn More
Parenteral drug product formulation development
We offer formulation development for all biologics modalities and dosage forms. Learn more.
Learn More
Drug Product Manufacture
We offer fully integrated biologics manufacturing services from selection and qualification of the...
Learn More
Biologics Regulatory Services
Partner with our dedicated biologics regulatory team to define the optimal regulatory strategy for...
Learn More
Biologics

Related Insights

Knowledge Center
Webinar on-demand
Webinar (on-demand)
Go from DNA to IND in 11 months guaranteed* with Ibex® Design 2.0
The increasing importance of speed to clinic puts pressure on biotherapeutics product development...
KC Whitepaper thumbnail
Whitepaper/Executive Summary
How Lonza’s Ibex® Design 2.0 Program Accelerates Time to IND
Speed to clinic and to market is increasingly gaining importance among biopharmaceutical drug...
Whitepaper/Executive Summary
De-risk Development and Manufacture of Bispecific Antibodies with Lonza
In this executive summary you'll discover why we are the CDMO to turn to when you want a faster path...
Knowledge Center

Latest news

View all Articles
31 Jan 2023
Media Advisory
Lonza Celebrates Groundbreaking of New Commercial Drug Product Facility in Stein
View Article
31 Jan 2023
Media Advisory
Lonza Celebrates Groundbreaking of New Commercial Drug Product Facility in Stein
View Article
30 Jan 2023
Media Advisory
Lonza Expands Manufacturing Collaboration With Asher Biotherapeutics to Include AB248, a...
View Article
30 Jan 2023
Media Advisory
Lonza Expands Manufacturing Collaboration With Asher Biotherapeutics to Include AB248, a...
View Article
17 Jan 2023
Media Advisory
Lonza Collaborates with Cristal Therapeutics and McSAF to Expand Bioconjugates Offering
View Article
17 Jan 2023
Media Advisory
Lonza Collaborates with Cristal Therapeutics and McSAF to Expand Bioconjugates Offering
View Article
9 Jan 2023
Media Advisory
Lonza and Context Therapeutics Enter Manufacturing Agreement for Bispecific Antibody Targeting...
View Article
9 Jan 2023
Media Advisory
Lonza and Context Therapeutics Enter Manufacturing Agreement for Bispecific Antibody Targeting...
View Article
View all Articles
Ways to Contact
  • Contact Us
  • Regulatory Support
  • Locations
  • Partnering with Us
Resources
  • Knowledge Center
  • Meet the Experts
  • Upcoming Events
Terms & Conditions
  • Terms and Conditions
  • Legal Disclaimer
  • Privacy Policy
  • California CCPA Notice
  • Transparency in Coverage
Lonza.com
  • Company Overview
  • News & Media
  • Investor Relations
  • Sustainability
  • Careers
  • Sitemap
© 2023 Lonza. All rights reserved.